Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-04-29

FDA Approved: FAMCICLOVIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a Teva Pharmaceuticals supplemental application for famciclovir, resulting in an updated indication/label for the generic antiviral.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famciclovir (famciclovir)

Snippet

SUPPL AP for FAMCICLOVIR (FAMCICLOVIR)